Cyclacel Pharmaceuticals Inc

NASDAQ:CYCC   3:59:53 PM EDT
1.23
+0.02 (+1.65%)
Earnings Announcements

Cyclacel Pharmaceuticals Reports First Quarter 2022 Results

Published: 05/11/2022 20:47 GMT
Cyclacel Pharmaceuticals Inc (CYCC) - Cyclacel Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Business Update.
Cyclacel Pharmaceuticals Inc - Cash Runway Through Mid-2023.
Cyclacel Pharmaceuticals Inc Qtrly Net Loss per Share - Basic and Diluted $0.42.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.54

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.55

More details on our Analysts Page.